carmustine has been researched along with Carcinoma, Ehrlich Tumor in 11 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The protein A24 content of Ehrlich ascites tumor cells increased several-fold following treatment of cell cultures with nitrosoureas, but did not increase when other alkylating agents not containing carbamoyl moieties were tested." | 1.27 | Inhibition of protein A24 lyase by nitrosoureas. ( Dornish, JM; Markussen, G; Smith-Kielland, I, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stukov, AN | 1 |
| Filatova, LV | 1 |
| Latipova, DKh | 1 |
| Bespalov, VG | 1 |
| Belyaeva, OA | 1 |
| Kireeva, GS | 1 |
| Vasilieva, IN | 1 |
| Alexandrov, VA | 1 |
| Maidin, MA | 1 |
| Semenov, AL | 1 |
| Vershinina, SF | 1 |
| Markochev, AB | 1 |
| Abduloeva, NKh | 1 |
| Chubenko, VA | 1 |
| Semiglazova, TY | 1 |
| Danø, K | 1 |
| Dornish, JM | 2 |
| Smith-Kielland, I | 2 |
| Markussen, G | 1 |
| Ritter, C | 1 |
| Iyengar, CL | 1 |
| Rutman, RJ | 3 |
| Furusawa, E | 2 |
| Lum, MK | 1 |
| Furusawa, S | 2 |
| Gromer, S | 1 |
| Schirmer, RH | 1 |
| Becker, K | 1 |
| Suzuki, N | 1 |
| Lee, JY | 1 |
| Bossa, R | 1 |
| Galatulas, I | 1 |
| Leotta, L | 1 |
| Tofanetti, O | 1 |
| Ritter, CA | 1 |
| Avadhani, NG | 2 |
| Hansel, J | 1 |
11 other studies available for carmustine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
[Therapeutic activity of gemcitabine in intracranial tumors].
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brai | 2015 |
Development of resistance to adriamycin (NSC-123127) in Ehrlich ascites tumor in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Carmustine; Cytarabine; Dose-Respons | 1972 |
Increases in protein A24 following treatment of Ehrlich ascites tumor cells with 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Carcinoma, Ehrlich Tumor; Carmustine; Cells, Cultured; Chromosomal Proteins, Non-Histone; D | 1981 |
Inhibition of protein A24 lyase by nitrosoureas.
Topics: Animals; Carcinoma, Ehrlich Tumor; Carmustine; Cyanates; Ethyl Methanesulfonate; Ethylnitrosourea; H | 1984 |
Differential enhancement of antitumor effectiveness by phospholipid vesicles (liposomes).
Topics: Animals; Biological Transport, Active; Carcinoma, Ehrlich Tumor; Carmustine; Cell Line; Cell Membran | 1981 |
Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carmu | 1981 |
The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase.
Topics: Animals; Carcinoma, Ehrlich Tumor; Carmustine; Humans; Mice; Molecular Weight; Placenta; Proteins; S | 1997 |
Combination chemotherapy of Rauscher leukemia and ascites tumors by narcissus alkaloid with standard drugs and effect on cellular immunity.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Blood Cells; Carcinoma, Ehrlich Tumor; Carmu | 1975 |
Effect of various antitumor drugs on energetic processes.
Topics: Animals; Antineoplastic Agents; Bleomycin; Brain; Carcinoma, Ehrlich Tumor; Carmustine; Cytarabine; | 1976 |
Liposomal potentiation of the antitumor activity of alkylating drugs.
Topics: Alkylating Agents; Animals; Carcinoma, Ehrlich Tumor; Carmustine; Drug Synergism; Leukemia L1210; Li | 1976 |
Distinctive effects of mechlorethamine (NSC-762), cyclophosphamide (NSC-26271), and BCNU (NSC-409962) on transcription in Ehrlich cells.
Topics: Adenosine Triphosphate; Alkylating Agents; Animals; Carcinoma, Ehrlich Tumor; Carmustine; Cell Nucle | 1976 |